Immediate Impact

5 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Osteoarthritis
2025 Standout
Injectable Microgels with Hybrid Exosomes of Chondrocyte‐Targeted FGF18 Gene‐Editing and Self‐Renewable Lubrication for Osteoarthritis Therapy
2024 Standout
1 intermediate paper

Works of A. DiFrancesco being referenced

A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
2021
Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
2020

Author Peers

Author Last Decade Papers Cites
A. DiFrancesco 247 60 8 139 130 11 507
Heidi Wong 259 69 12 156 95 11 553
Diana C. Brinson 249 51 5 100 75 11 553
C. I. Westacott 265 52 3 113 88 16 465
Valérie Dessirier 63 65 1 157 58 14 523
Peter LEM van Lent 272 50 2 111 75 9 428
Alfons S.K. de Hooge 172 33 4 220 72 9 515
Christopher J. Elson 168 74 2 149 39 8 491
Jennifer M Milner 214 56 2 48 71 11 529
Brian Wu 222 60 2 53 74 9 474
T Leizer 170 34 3 180 27 15 534

All Works

Loading papers...

Rankless by CCL
2026